PBRM1 and nonpapillary renal cell carcinoma: We employed an isogenic murine RCC model to investigate the impact of PBRM1 loss on tumor-autonomous IFNγ signaling and on the TME, measured the effect of PBRM1 loss on response to ICB, and validated our findings in human ccRCC datasets.